Medtronic CEO Ishrak nixes a possible Spine spinout

     
 
 
Medtronic CEO Ishrak nixes spine spinout (MassDevice)

Medtronic CEO Omar Ishrak puts the kaibosh on suggestions that the company ditch its spine business, saying all parts add value – except Physio-Control.

Medtronic (NYSE:MDT) CEO Omar Ishrak put the kaibosh on a spinout for the company's spine business, telling Reuters that all of the company's parts add up to a greater whole, with one notable exception – its Physio-Control external defibrillator unit.
"[O]ur assessment is that the different pieces of Medtronic [together] actually add value," Ishrak told the news serv...